Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
2.970
+0.090 (3.13%)
Nov 5, 2024, 10:14 AM EST - Market open

Editas Medicine Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
-210.57-153.22-220.43-192.5-115.98-133.75
Upgrade
Depreciation & Amortization
5.896.066.345.053.962.83
Upgrade
Asset Writedown & Restructuring Costs
----27.5-
Upgrade
Loss (Gain) From Sale of Investments
-3.35-4.82-0.721.66-16.37-
Upgrade
Stock-Based Compensation
22.7419.829.2943.423.1627.24
Upgrade
Other Operating Activities
-2.491.6--0.1-2.93
Upgrade
Change in Accounts Receivable
2.3-5.04-4.885.78-5.63-0.39
Upgrade
Change in Accounts Payable
2.12-1.494.37-1.140.860.27
Upgrade
Change in Unearned Revenue
---3.33-22.71-91.7955.4
Upgrade
Change in Other Net Operating Assets
3.054.9412.02-3.35-5.6510.65
Upgrade
Operating Cash Flow
-181.76-132.18-177.35-163.8-179.84-40.67
Upgrade
Capital Expenditures
-9.59-4.72-4.12-7.98-7.16-6.17
Upgrade
Sale of Property, Plant & Equipment
--0.02-0.010.1
Upgrade
Investment in Securities
203.620.99118.17-46.49-133.3718.32
Upgrade
Investing Cash Flow
194.03-3.73114.07-54.47-140.5212.25
Upgrade
Issuance of Common Stock
1.03118.041.28282.11224.12131.82
Upgrade
Financing Cash Flow
1.03118.041.28282.11224.12131.82
Upgrade
Net Cash Flow
13.29-17.87-6263.84-96.24103.41
Upgrade
Free Cash Flow
-191.36-136.9-181.47-171.78-187.01-46.84
Upgrade
Free Cash Flow Margin
-309.84%-175.23%-920.59%-672.49%-206.11%-228.12%
Upgrade
Free Cash Flow Per Share
-2.33-1.80-2.64-2.54-3.19-0.94
Upgrade
Levered Free Cash Flow
-131.19-87.81-102.27-85.55-77.36-46.79
Upgrade
Unlevered Free Cash Flow
-131.19-87.81-102.27-85.55-77.36-46.79
Upgrade
Change in Net Working Capital
-9.993.21-7.445.3113.04-17.38
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.